Epidemiological neuropathology: The MRC cognitive function and aging study experience

Journal of Alzheimer's Disease

Volumn 25, Issue 2, 2011, Pages 359-372

  Wharton, Stephen B ^a   Brayne, Carol ^b   Savva, George M ^b   Matthews, Fiona E ^b   Forster, Gill ^a   Simpson, Julie ^a   Lace, Gemma ^a   Ince, Paul G ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Alzheimer's disease; cerebrovascular disease; dementia; epidemiology; Lewy bodies; longitudinal studies; neurofibrillary tangles

Indexed keywords

ALPHA SYNUCLEIN; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN; CASE CONTROL STUDY; CLINICAL ASSESSMENT; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; CORRELATION ANALYSIS; DEATH; DEMENTIA; DISEASE COURSE; GLIA CELL; HEALTH; HUMAN; MEDICAL EDUCATION; MEDICAL RESEARCH; NERVE CELL DEGENERATION; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN DONOR; PATHOLOGY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; STUDY DESIGN; UNITED KINGDOM; VASCULAR DISEASE; WHITE MATTER;

EID: 79959764715     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-091402     Document Type: Article

References (74)

1. Zaccai J, Ince P, Brayne C (2006) Population-based neu-ropathological studies of dementia: design, methods and areas of investigation - a systematic review. BMC Neurol 6, 2.
2. MRC-CFAS (1998) Cognitive function and dementia in six areas of England and Wales: the distribution of MMSE and prevalence of GMS orgnanicity level in the MRC CFA study. Psychol Med 28, 319-335.
3. Brayne C, McCracken C, Matthews FE(2006) Cohort profile: the Medical Research Council Cognitive Function and Aging Study (CFAS). Int J Epidemiol 35, 1140-1145. (Pubitemid 44605527)
4. Copeland JR, Dewey ME, Griffiths-Jones HM (1986) A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychol Med 16, 89-99. (Pubitemid 16130410)
5. Copeland JR, Kelleher MJ, Kellett JM, Gourlay AJ, Gurland BJ, Fleiss JL, Sharpe L (1976) A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly: the Geriatric Mental State Schedule. I. Development and reliability. Psychol Med 6, 439-449.
6. Huppert FA, Brayne C, Gill C, Paykel ES, Beardsall L (1995) CAMCOG - a concise neuropsychological test to assist dementia diagnosis: socio-demographic determinants in an elderly population sample. Br J Clin Psychol 34(Pt 4), 529-541.
7. Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C (2009) Age, neuropathology, and dementia. N Engl J Med 360, 2302-2309.
8. MRC-CFAS (2001) Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 357, 169-175.
9. Mirra S, Heyman A, McKeel D, Sumi S, Crain B, Brown-lee L, Vogel F, Hughes J, Van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardisation of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479-486.
10. Matthews F, Brayne C, Lowe J, McKeith I, Wharton S, Ince P (2009) Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Aging Study. PLoS Med 6, e1000180.
11. Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82, 239-259.
12. Thal D, Rub U, Orantes M, Braak H (2002) Phases of Ab-deposition in the human brain and its relevance for the development of AD. Neurology 58, 1791-1800. (Pubitemid 34663580)
13. Bennett D, Schneider J, Arvanitakis Z, Kelly J, Aggarwal N, Shah R, Wilson R (2006) Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66, 1837-1844. (Pubitemid 44049813)
14. Green S, Kaye J, Ball M (2000) The Oregon Brain Aging Study: neuropathology accompanying healthy aging in the oldest old. Neurology 54, 105-113. (Pubitemid 30038746)
15. Knopman D, Parisi J, Salviati A, Floriach-Robert M, Boeve B, Ivnik R, Smith G, Dickson D, Johnson K, Petersen L, McDonald W, Braak H, Petersen R (2003) Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol 62, 1087-1095. (Pubitemid 37413820)
16. Schoenmaker N, Van Gool W (2004) The age gap between patients in clinical studies and in the general population: a pitfall for dementia research. Lancet Neurol 3, 627-630. (Pubitemid 39221930)
17. Schneider J, Arvanitakis Z, Bang W, Bennett D (2007) Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69, 2193-2194.
18. Berg L, McKeel D, Miller J, Storandt M, Rubin E, Morris J, Baty J, Coats M, Norton J, Goate A, Price J, Gearing M, Mirra S, Saunders A (1998) Clinicopathologic studies in cognitively healthy aging and Alzheimer disease. Relation of histologic markers to dementia severity, age, sex and apolipoprotein E genotype. Arch Neurol 55, 326-335. (Pubitemid 28146197)
19. Mann D, Yates P, Marcyniuk B (1985) Some morphomet-ric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age. J Neurol Sci 69, 139-159. (Pubitemid 15074612)
20. Prohovnic I, Perl D, Davis K, Libow L, Lesser G, Haroutunian V (2006) Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease. Neurology 66, 49-55. (Pubitemid 43739591)
21. Haroutunian V, Schnaider-Beeri M, Schmeidler J, Wysocki M, Purohit D, Perl D, Libow L, Lesser G, Maroukian M, Grossman HT (2008) Role of the neuropathol-ogy of Alzheimer disease in dementia in the oldest old. Arch Neurol 65, 1211-1217.
22. Terry R, Masliah E, Salmon D, Butters N, De Teresa R, Hill R, Hansen L, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30, 572-580.
23. Wilson R, Scherr P, Schneider J, Tang Y, Bennett D (2007) Relation of cognitive activity to risk of developing Alzheimer disease. Neurology 69, 1911-1920. (Pubitemid 350100349)
24. Cotman C, Berchtold N, Christie L-A (2007) Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci 30, 464-472. (Pubitemid 47374831)
25. Frataglioni L, Paillard-Borg S, Winblad B (2004) An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol 3, 343-353. (Pubitemid 38648855)
26. Ngandu T, Von Strauss E, Helkala E-L, Winblad B, Nissinen A, Tuomilehto J, Soininen H, Kivipelto M (2007) Education and dementia. What lies behind the association? Neurology 69, 1442-1450. (Pubitemid 47511466)
27. Smith G, Pankratz V, Negash S, Machulda M, Petersen R, Boeve B, Knopman D, Lucas J, Ferman T, Graff-Radford N, Ivnik R (2007) A plateau in pre-Alzheimer memory decline. Evidence for compensatory mechanisms? Neurology 69, 133-139. (Pubitemid 47051717)
28. Terry R, Katzman R (2001) Life span and synapses: will there be a primary senile dementia? Neurobiol Aging 22, 347-348. (Pubitemid 32510903)
29. Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H, Bugiani O, Del-Tredici K, Ferrer I, Gelpi E, Giaccone G, Graeber MB, Ince P, Kamphorst W, King A, Korkolopoulou P, Kovacs GG, Larionov S, Meyronet D, Monoranu C, Parchi P, Patsouris E, Roggendorf W, Seilhean D, Tagliavini F, Stadelmann C, Streichenberger N, Thal DR, Wharton SB, Kretzschmar H (2008) Staging of neurofibril-lary pathologyin Alzheimer's disease:a study ofthe Brain Net Europe Consortium. Brain Pathol 18, 484-496.
30. Alafuzoff I, Ince PG, Arzberger T, Al-Sarraj S, Bell J, Bodi I, Bogdanovic N, Bugiani O, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kovacs GG, Meyronet D, Monoranu C, Parchi P, Parkkinen L, Patsouris E, Roggendorf W, Rozemuller A, Stadelmann-Nessler C, Streichenberger N, Thal DR, Kretzschmar H (2009) Staging/typing of Lewy body related alpha-synuclein pathology: a study of the Brain Net Europe Consortium. Acta Neuropathol 117, 635-652.
31. Alafuzoff I, Parkkinen L, Al-Sarraj S, Arzberger T, Bell J, Bodi I, Bogdanovic N, Budka H, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Kamphorst W, King A, Korkolopoulou P, Kovacs GG, Larionov S, Meyronet D, Monoranu C, Morris J, Parchi P, Patsouris E, Roggendorf W, Seilhean D, Streichenberger N, Thal DR, Kretzschmar H (2008) Assessment of alpha-synuclein pathology: a study of the Brain Net Europe Consortium. J Neuropathol Exp Neurol 67, 125-143.
32. Alafuzoff I, Pikkarainen M, Al-Sarraj S, Arzberger T, Bell J, Bodi I, Bogdanovic N, Budka H, Bugiani O, Ferrer I, Gelpi E, Giaccone G, Graeber MB, Hauw JJ, Kamphorst W, King A, Kopp N, Korkolopoulou P, Kovacs GG, Meyronet D, Parchi P, Patsouris E, Preusser M, Ravid R, Roggendorf W, Seilhean D, Streichenberger N, Thal DR, Kretzschmar H (2006) Interlaboratory comparison of assessments of Alzheimer disease-related lesions: a study of the Brain Net Europe Consortium. J Neuropathol Exp Neurol 65, 740-757. (Pubitemid 44200315)
33. Alafuzoff I, Pikkarainen M, Arzberger T, Thal DR, Al-Sarraj S, Bell J, Bodi I, Budka H, Capetillo-Zarate E, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Kavantzas N, King A, Korkolopoulou P, Kovacs GG, Meyronet D, Monoranu C, Parchi P, Patsouris E, Roggendorf W, Stadelmann C, Streichenberger N, Tagliavini F, Kretzschmar H (2008) Interlaboratory comparison of neuropathological assessments of beta-amyloid protein: a study of the Brain Net Europe consortium. Acta Neuropathol 115, 533-546.
34. Alafuzoff I, Thal D, Arzberger T, Bogdanovic N, Al-Sarraj S, Bodi I, et al. (2009) Assessment of fj-amyloid deposits in human brain: a study of the Brain Net Europe Consortium. Acta Neuropathol 117, 309-320.
35. Byford M, Brayne C, McKeith I, Chatfield M, Ince P, Matthews F (2009) Lewy bodies and neuronal loss in subcortical areas and disability in non-demented older people: a population based neuropathological cohort study. BMC Geriatr 9, 22.
36. Braak H, Rub U, Schultz C, Del Tredici K (2006) Vulnerability of cortical neurons to Alzheimer's and Parkinson's diseases. J Alzheimers Dis 9, 35-44. (Pubitemid 44253296)
37. Esiri M, Chance S (2006) Vulnerability to Alzheimer's pathology in neocortex: the roles of plasticity and columnar organisation. J Alzheimers Dis 9, 79-89. (Pubitemid 44253301)
38. Gauthier S, Reisberg B, Zaudig M, Petersen R, Ritchie K, Broich K, et al. (2006) Mild cognitive impairment. Lancet 367, 1262-1270.
39. Lace G, Savva GM, Forster G, de Silva R, Brayne C, Matthews FE, Barclay JJ, Dakin L, Ince PG, Wharton SB (2009) Hippocampal tau pathology is related to neuroanatomical connections: an aging population-based study. Brain 132, 1324-1334.
40. Thal D, Holzer M, Rub U, Waldmann G, Gunzel S, Zedlick D, Schober R (2000) Alzheimer-related tau pathology in the per-forant path target zone and in the hippocampal stratum oriens and radiatum correlates with onset and degree of dementia. Exp Neurol 163, 98-110. (Pubitemid 30314364)
41. McKeith I, Dickson D, Lowe J, Emre M, O'Brien J, Feldman H, et al. (2005) Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium. Neurology 65, 1863-1872. (Pubitemid 43970103)
42. Braak H, Del Tredici K, Rub U, de Vos R, Jansen-Steur E, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24, 197-211. (Pubitemid 36007810)
43. Hawkes C, Del Tredici K, Braak H (2007) Review: Parkinson's disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 33, 599-614. (Pubitemid 350076090)
44. Kalaitzakis M, Graeber M, Gentleman S, Pearce R (2008) The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of a-synuclein staging. Neuropathol Appl Neurobiol 34, 284-295. (Pubitemid 351590870)
45. Parkinnen L, Pirttila T, Alafuzoff I (2008) Applicability of current staging/categorization of a-synuclein pathology and their clinical relevance. Acta Neuropathol 115, 399-407.
46. Zaccai J, Brayne C, McKeith I, Matthews F, Ince P (2008) MRC Cognitive Function, Aging Neuropathology Study. Patterns and stages of alpha-synucleinopathy: relevance in a population-based cohort. Neurology 70, 1042-1048.
47. Uchikado H, Lin W, De Lucia M, Dickson D (2006) Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 65, 685-697. (Pubitemid 44297259)
48. Hamilton R (2000) Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using a-synuclein immunohistochemistry. Brain Pathol 10, 378-384. (Pubitemid 30431290)
49. Volterra A, Meldolesi J (2005) Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 6, 626-640. (Pubitemid 41059337)
50. Maragakis N, Rothstein J (2006) Mechanisms of disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 2, 679-689. (Pubitemid 44782682)
51. Vehmas A, Kawas C, Stewart W, Troncoso J (2003) Immune reactive cells in senile plaques and cognitive decline in Alzheimer's disease. Neurobiol Aging 24, 321-331. (Pubitemid 36005412)
52. Nagele R, Wegiel J, Venkataraman V, Iamki H, Wang K-C, Wegiel J (2004) Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease. Neurobiol Aging 25, 663-674. (Pubitemid 38686490)
53. Meda L, Baron P, Scarlato G (2001) Glial activation in Alzheimer's disease: the role of Ab and its associated proteins. Neurobiol Aging 22, 885-893. (Pubitemid 34066555)
54. Rodriguez JJ, Olabarria M, Chvatal A, Verkhratsky A (2009) Astroglia in dementia and Alzheimer's disease. Cell Death Differ 16, 378-385.
55. Simpson J, Ince P, Lace G, Forster G, Shaw P, Matthews F, Savva G, Brayne C, Wharton S, on behalf of the MRC Cognitive Function and Aging Neuropathology Study Group (2010) Astrocyte phenotype in relation to Alzheimer-type pathology in the aging brain. Neurobiol Aging 31, 578-590.
56. Kashon M, Ross G, O'Callaghan J, Miller D, Petrovitch H, Burchfield C, Sharp D, Markesbery W, Davies D, Hardman J, Nelson J, White L (2004) Associations of cortical astrogliosis with cognitive performance and dementia status. J Alzheimers Dis 6, 595-604. (Pubitemid 40164166)
57. Wharton SB, O'Callaghan JP, Savva GM, Nicoll JA, Matthews F, Simpson JE, Forster G, Shaw PJ, Brayne C, Ince PG (2009) Population variation in glial fibrillary acidic protein levels in brain aging: relationship to Alzheimer-type pathology and dementia. Dement Geriatr Cogn Disord 27, 465-473.
58. Simpson J, Ince P, Haynes L, Theaker R, Gelsthorpe C, Baxter L, Forster G, Lace G, Shaw P, Matthews F, Savva G, Brayne C, Wharton S (2010) On behalf of the MRC Cognitive Function and Aging Neuropathology Study Group. Population variation in oxidative stress and astrocyte DNA damage in relation to Alzheimer-type pathology in the aging brain. Neuropathol Appl Neurobiol 36, 25-40.
59. Munoz D (2006) Leukoaraiosis and ischaemia. Beyond the myth. Stroke 37, 1348-1349.
60. De Leeuw F-E, De Groot J, Achten E, Oudkerk M, Ramos L, Heijboer R, Hofman A, Jolles J, Van Gijn J, Breteler M (2001) Prevalence of cerebral white matter lesions in elderly people:apopulationbased magnetic resonanceimaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiat 70, 9-14. (Pubitemid 32096113)
61. Launer L, Berger K, Breteler M, Dufouil C, Fuhrer R, Giampaoli S, Nilsson L, Pajak A, de Ridder M, van Dijk E, Sans S, Schmidt R, Hofman A (2006) Regional variability in the prevalence of cerebral white matter lesions: an MRI study in 9 European countries (CASCADE). Neuroepidemiology 26, 23-29. (Pubitemid 41797934)
62. Piguet O, Ridley L, Grayson D, Bennett H, Creasey H, Lye T, Broe G (2003) Are MRI white matter lesions clinically significant in the 'old-old'? Evidence from the Sydney Older Persons Study. Dement Geriatr Cogn Disord 15, 143-150. (Pubitemid 36206643)
63. Barber R, Scheltens P, Gholkar A, Ballard C, McKeith I, Ince P, Perry R, O'Brien J (1999) White matter lesions on magentic resonance imaging in dementia wth Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiat 67, 66-72. (Pubitemid 29278329)
64. Breteler M, Van Swieten J, Bots M, Grobbee D, Claus J, Van Den Hout J, Van Harskamp F, Tanghe H, De Jong P, Van Gijn J, Hofman A (1994) Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 44, 1246-1252. (Pubitemid 24232223)
65. Fernando M, Ince P (2004) Vascular pathologies and cognition in a population-based cohort of elderly people. J Neurol Sci 226, 13-17. (Pubitemid 39505399)
66. Fernando M, O'Brien J, Perry R, English P, Forster G, McMeekin W, Slade J, Golkhar A, Matthews F, Barber R, Kalaria R, Ince P (2004) Comparison of the pathology of cerebral white matter with post-mortem magnetic resonance imaging (MRI) in the elderly brain. Neuropathol Appl Neu-robiol 30, 385-395. (Pubitemid 39120300)
67. Simpson JE, Fernando M, Clark L, Ince P, Matthews F, Forster G, O'Brien J, Barber R, Kalaria R, Brayne C, Shaw P, Lewis C, Wharton S (2007) White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendro-cyte precursor cell responses. Neuropathol Appl Neurobiol 33, 410-419. (Pubitemid 47037889)
68. Simpson J, Ince P, Higham C, Gelsthorpe C, Fernando M, Matthews F, Forster G, O'Brien J, Barber R, Kalaria R, Brayne C, Shaw P, Stoeber K, Williams G, Lewis C, Wharton S, On behalf of the MRC Cognitive Function and Aging Neuropathology Study Group (2007) Microglial activation in white matter lesions and nonlesional white matter of aging brains. Neuropathol Appl Neurobiol 33, 670-683. (Pubitemid 350076092)
69. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson L-A, Nilsson L, Persson G, Oden A, Svanborg A (1996) 15-year longitudinal study of blood pressure and dementia. Lancet 347, 1141-1145. (Pubitemid 126512042)
70. Wardlaw J (2005) What causes lacunar stroke? J Neurol Neu-rosurg Psychiat 76, 617-619. (Pubitemid 40569666)
71. Fernando M, Simpson J, Matthews F, Brayne C, Lewis C, Barber R, Kalaria R, Forster G, Esteves F, Wharton S, Shaw P, O'Brien J, Ince P (2006) White matter lesions in an uns-elected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke 37, 1391-1398. (Pubitemid 44305715)
72. Simpson J, El-Sayad O, Wharton S, Heath P, Holden H, Fernando M, Matthews F, Forster G, O'Brien J, Barber R, Kalaria R, Brayne C, Shaw P, Lewis C, Ince P (2009) Medical Research Council Cognitive Function and Aging Study Neuropathology Group. Microarray RNA expression analysis of cerebral white matter lesions reveals changes in multiple functional pathways. Stroke 40, 369-375.
73. Simpson J, Wharton S, Cooper J, Gelsthorpe C, Baxter L, Forster G, Shaw P, Savva G, Matthews F, Brayne C, Ince P (2010) Alterations of the blood-brain barrier in cerebral white matter lesions in the aging brain. Neurosci Lett 486, 246-251.
74. Keage H, Carare R, Friedland R, Ince P, Love S, Nicoll J, Wharton S, Weller R, Brayne C (2009) Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review. BMC Neurol 9, 3. )